Cargando…
Teicoplanin—A New Use for an Old Drug in the COVID-19 Era?
Teicoplanin is an antibiotic that has been actively used in medical practice since 1986 to treat serious Gram-positive bacterial infections. Due to its efficiency and low cytotoxicity, teicoplanin has also been used for patients with complications, including pediatric and immunocompromised patients....
Autor principal: | Vimberg, Vladimir |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708781/ https://www.ncbi.nlm.nih.gov/pubmed/34959628 http://dx.doi.org/10.3390/ph14121227 |
Ejemplares similares
-
Teicoplanin: an alternative drug for the treatment of COVID-19?
por: Baron, Sophie Alexandra, et al.
Publicado: (2020) -
Is Therapeutic Drug Monitoring of Teicoplanin Useful?
por: Kim, Shin-Woo
Publicado: (2014) -
Elucidation of Teicoplanin Interactions with Drug Targets Related to COVID-19
por: Azam, Faizul
Publicado: (2021) -
Therapeutic Drug Concentrations of Teicoplanin in Clinical Settings
por: Nah, So-Yun, et al.
Publicado: (2014) -
Optimal Use and Need for Therapeutic Drug Monitoring of Teicoplanin in Children: A Systematic Review
por: Choi, Joon-sik, et al.
Publicado: (2023)